Risks and benefits of biologic therapy for inflammatory bowel diseases.
D'Haens
Geert
G
Imelda GI Clinical Research Centre, Imeldalaan 9, 2820 Bonheiden, Belgium. geert.dhaens@imelda.be
D001691:Biological Therapy / Q000009:adverse effects*; D016207:Cytokines / Q000378:metabolism; D003875:Drug Eruptions / Q000209:etiology; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000628:therapy*; D009369:Neoplasms / Q000209:etiology; D009894:Opportunistic Infections / Q000209:etiology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy; D018570:Risk Assessment
D016207:Cytokines